Is IceCure Medical Ltd. (ICCM) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.1% / 30% | 17.4% / 30% | 0.9% / 30% | 0.0% / 5% | ✓ HALAL |
| DJIM | 1.1% / 33% | 17.4% / 33% | 0.9% / 33% | 0.0% / 5% | ✓ HALAL |
| MSCI | 3.6% / 33% | 60.1% / 33% | 3.3% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| S&P | 1.1% / 33% | 17.4% / 33% | 0.9% / 33% | 0.0% / 5% | ✓ HALAL |
| FTSE | 3.6% / 33% | 60.1% / 33% | 3.3% / 50% | 0.0% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 36.3% | |
| Operating Margin | -329.6% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -188.8% | |
| Return on Assets (ROA) | -71.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$15M |
| Free Cash Flow | -$15M |
| Total Debt | $217,000 |
| Debt-to-Equity | 2.4 |
| Current Ratio | 2.6 |
| Total Assets | $14M |
Price & Trading
| Last Close | $0.39 |
| 50-Day MA | $0.61 |
| 200-Day MA | $0.80 |
| Avg Volume | 287K |
| Beta | 2.3 |
|
52-Week Range
$0.37
| |
About IceCure Medical Ltd. (ICCM)
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is IceCure Medical Ltd. (ICCM) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), IceCure Medical Ltd. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is IceCure Medical Ltd.'s debt ratio?
IceCure Medical Ltd.'s debt ratio is 1.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.6%.
What are IceCure Medical Ltd.'s key financial metrics?
IceCure Medical Ltd. has a market capitalization of $27M, and revenue of $3M. Return on equity stands at -188.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.